Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...
ATLANTA — For the second straight year, Cleveland arrived in Atlanta with a chance to push through to the knockout round of the NBA Cup, and for the second straight year, the Hawks snatched that hope ...
Godofredo A. Vásquez / AP Deni Avdija had 26 points, a career-high 14 assists and six rebounds as the Portland Trail Blazers held off the Golden State Warriors 127-123 in the NBA Cup on Friday night.
Your favorite latte at the local coffee shop could soon cost $5, $5.10 or $5.25—depending on how you pay. A settlement between Visa, Mastercard and U.S. merchants announced this week could usher in a ...
Inside the financial engineering of the AI build-out: Nvidia, Google and the rest of Big Tech are turning to Wall Street, vendor financing and private credit In a rural Louisiana parish that is home ...
After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...
SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback